BGA — BioNeutra Global Balance Sheet
0.000.00%
- CA$2.09m
- CA$8.84m
- CA$11.38m
- 43
- 78
- 24
- 46
Annual balance sheet for BioNeutra Global, fiscal year end - December 31st, CAD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 0.523 | 0.934 | 0.839 | 0.723 | 1.89 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 3.3 | 1.64 | 1.73 | 1.1 | 1.22 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Current Assets | 20.6 | 12.5 | 10.9 | 9.71 | 6.97 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 12.3 | 10.6 | 9.75 | 9.64 | 8.47 |
Net Intangible Assets | |||||
Long Term Investments | |||||
Total Assets | 34 | 23.7 | 21.1 | 19.8 | 15.8 |
Payable / Accrued | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 22.5 | 16.6 | 15.8 | 16.9 | 14.8 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Total Other Liabilities | |||||
Total Liabilities | 29.3 | 23 | 22.1 | 23.5 | 22 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
ESOP Debt Guarantee | |||||
Other Equity | |||||
Total Equity | 4.75 | 0.701 | -1.03 | -3.76 | -6.19 |
Total Liabilities & Shareholders' Equity | 34 | 23.7 | 21.1 | 19.8 | 15.8 |
Total Common Shares Outstanding |